Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Surg Case Rep ; 2024(5): rjae272, 2024 May.
Article in English | MEDLINE | ID: mdl-38706491

ABSTRACT

Endometriosis is known to occur frequently in adolescents with obstructed Müllerian anomalies. Our cases emphasize that endometriosis can rapidly progress to a severe stage in obstructed hemivagina and ipsilateral renal anomaly syndrome, one of the completely obstructed Müllerian anomalies. The first patient was a 14-year-old girl who complained of cyclic abdominal pain. Imaging revealed a uterine didelphys with unilateral hematocolpos and a left adnexal endometrioma. The second, an 11-year-old girl, visited the hospital complaining of cyclic abdominal pain, had a unicornuate uterus with a functioning horn and left adnexal endometrioma. Also, both patients had unilateral renal agenesis. The surgery in both cases revealed Stage IV endometriosis. Adjuvant hormone therapy was administered for 1 year, and there was no recurrence until 3 years after surgery. We emphasize that patients diagnosed with renal agenesis should be screened to check for gynecological anomalies when menstrual cramps occur after menarche.

2.
BMC Res Notes ; 6: 319, 2013 Aug 12.
Article in English | MEDLINE | ID: mdl-23937919

ABSTRACT

BACKGROUND: Small follicular cysts are commonly found in the ovaries of prepubertal girls, and in most cases, they are of no clinical importance. These cysts are usually self-limiting and resolve spontaneously. However, occasionally, these cysts may enlarge and continue to produce estrogen, resulting in signs of sexual precocity. Here, we report a case of precocious pseudopuberty associated with an autonomous ovarian follicular cyst. CASE PRESENTATION: A 5.9-year-old girl initially presented to a local clinic with vaginal bleeding and a large unilateral ovarian cyst. At 6 months after the initial acute episode, the patient visited our hospital as the ovarian cyst had persisted and increased in size. Endocrinological examination showed elevated estrogen levels and suppressed gonadotropin levels on GnRH stimulation test. Also, no skin pigmentation or bone anomaly was noted. Based on these observations, laparoscopic cystectomy was performed, and histologic analysis confirmed the diagnosis of a follicular cyst. After the laparoscopic cystectomy, the patient's hormone levels returned to normal and no ovarian cyst was detected by ultrasound. CONCLUSIONS: As autonomous ovarian cysts are usually self-limiting disorder, no treatment is necessary. Therefore, surgical management should be deferred as long as possible to avoid the risk of repeat surgery, as pseudoprecocious puberty due to autonomous ovarian cysts can resolve spontaneoulsy and frequently recurs. Precocious pseudopuberty with an ovarian cyst may be due to granulosa cell tumor or may be one symptom of the McCune-Albright Syndrome (MAS). A careful longer-term follow up of patients with autonomous ovarian cysts and/or molecular studies may be necessary in such cases.


Subject(s)
Cystectomy , Follicular Cyst/pathology , Ovarian Cysts/pathology , Puberty, Precocious/pathology , Child , Estrogens/blood , Female , Follicular Cyst/complications , Follicular Cyst/diagnosis , Follicular Cyst/surgery , Gonadotropins/blood , Humans , Laparoscopy , Ovarian Cysts/complications , Ovarian Cysts/diagnosis , Ovarian Cysts/surgery , Puberty, Precocious/diagnosis , Puberty, Precocious/etiology , Puberty, Precocious/surgery
3.
Arch Pharm Res ; 33(4): 523-30, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20422360

ABSTRACT

To observe the protective effect of orally administrated Rexflavone (Sophorae fructus extract) for the postmenopausal symptoms, a randomized double-blind placebo controlled clinical trial was designed. Rexflavone significantly improved 11 menopausal symptoms including hot flash, which was evaluated by the modified Kupperman Index (KI), while hormone level and lipid profile were little changed by consumption. Rexflavone group significantly decreased KI score (-14.91 +/- 8.79) compared to placebo group (-11.45 +/- 6.62) as a representative index for improvement of menopausal symptoms (p < 0.05). We found that Rexflavone has no adverse effect to be safe for long term consumption. It was shown that the consumption of Rexflavone possessed beneficial effects on the postmenopausal symptoms in postmenopausal women.


Subject(s)
Hot Flashes/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Postmenopause/drug effects , Sophora/chemistry , Administration, Oral , Adult , Affective Symptoms/blood , Affective Symptoms/drug therapy , Anxiety/blood , Anxiety/drug therapy , Dietary Supplements , Double-Blind Method , Estradiol/blood , Female , Follicle Stimulating Hormone/blood , Fruit/chemistry , Hot Flashes/blood , Humans , Hypesthesia/blood , Hypesthesia/drug therapy , Lipids/blood , Middle Aged , Plant Extracts/administration & dosage , Plant Extracts/adverse effects , Postmenopause/blood , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...